Due Diligence Facilitation to Prepare for Deal Negotiations

The Client

• Small but well-funded, clinical stage biopharmaceutical company seeking IND-ready or later oncology assets to complement and expand its pipeline
• Client not positioned to compete with global pharma for best assets so needed to consider more marginal opportunities and ID “diamonds in the rough”

Challenge

• The company was seeking to assemble an expert due diligence team to augment its experts and conduct a scientific review of pitch slides and data room
• The company needed “go/no-go” recommendations, recommendations for additional studies to get to “go” or derisk, and suggestions for future development

Approach

• Conduct detailed scientific review of pitch decks and data rooms and relevant scientific literature for assets of interest
• Liaise with client’s scientific experts and executive management and provide detailed assessment and rationale for go/no-go recommendations.

Valued Outcome